As quarterly losses will continue into the foreseeable future, it still seems expensive at current levels.
It could be the next rare disease giant in the industry.
With shares trading near their recent 52-week low, it currently looks like a bargain.
Given its revenue growth, starting a small position at current levels might be a solid long-term investment.
It’s one of the purest plays in the new market being referred to as the metaverse.
This once-darling of Wall Street has seen its stock price fall 86% from all-time highs.
With 50% returns possible, it offers a cheaper and less volatile way to play the electric vehicle sector.
Despite its esteemed position, the stock has been in a correction since peaking at a 52-week peak north of $74; it recently set a 52-week low of $27.48 earlier this month. Is it time to bet on this industry leader?